shows the time course of glucocorticoid secretion for two children, one with normal GH levels and one with GH deficiency. The sequence of events after insulin administration at the start of the test is (at about 20-min intervals) 1) most intensive hypoglycemia, 2) highest glucocoi-ticoid levels, and 3) GH secretion. As the GH secretory episode occurs at the same time as or shortly after the glucocorticoid secretory eisode, GH cannot directly stimulate or inhibit corticosterone secretion during this test.
The glucose, cortisol, and corticosterone responses to insulininduced hypoglycemia in GH-deficient and control children are summarized in Table 1 . There was no significant difference between GH-deficient children and controls with respect to baseline cortisol, cortisol after insulin, glucose nadir, 01 baseline corticosterone. However, GH-deficient children had significantly higher corticosterone levels 40 min after the insulin injection. As expected, there was a significant difference in serum SmC levels between the two groups.
After 3 days of GH therapy, SmC levels increased from 0.31 The effect of a 3-day course of GH treatment on corticostero~ne secretion in response to an ACTH bolus is shown in Figure 2 . For comparative purposes the responses of children of normal stature to ACTH are also shown (C). Thus, the increased corticosterone response to endogenous ACTH (released in response to hypoglycemia) was also observed in response to exogenous ACTH. When the two children with ACTH deficiency (and thus decreased cortisol and corticosterone secretion) are excluded from the calculation, the mean corticosterone response to exo~g-enous ACTH was 2.42 + 0.22 pg/dl for GH-deficient children prior to treatment versus 1.53 + 0.19 pg/dl for children of normal stature ( p < 0.01 by both Student's t test and Wilcoxon rank sum test). ![n the short children that comprised our non-GH deficient group (B), the corticosterone levels after ACTH administration were 2.0 + 0.5 pg/dl. However, one of these children had extremely high corticosterone (5 pg/dl) levels in response to ACTH. This child was dysmorphic and extremely short, had a very delayed bone age, and had a severely disturbed honne environment but was not GH deficient and did not respond to GH therapy; we could not determine the exact cause of her short stature or the cause of the high serum corticosterone levels secreted in ]response to ACTH.
GH treatment did not change the suppressed baseline cortisol (< 1.0 pg/dl) and corticosterone (< 0.1 pg/dl) levels. The cortisol pg/dl before and 16 + 2 ~g / d l afte 3 days of GH). In the non-GH-deficient children, GH treatment also had no significant effect on the stimulated cortisol response to ACTH (19 +_ ~g / d l before GH and 18 2 4 pg/dl after GH).
In the children with GH deficiency, there was a significant (2.2 i 0.2 versus 1.6 + 0.2 pgldl; 1 = 5.22, p < 0.00 1) decrease in the corticosterone level after ACTH stimulation after 3 days of G H treatment. 'This decrease was seen both in children with normal ACTH reserves and in the two children with evidence of ACTH deficiency. In the non-GH-deficient children, the corticosterone response to ACTH showed a statistically significant decrease ( t = 2.73, p < 0.05), but the magnitude of the decrease was much smaller than in the children with G H deficiency (0.56 +-0.1 1 versus 0.12 + 0.05 pgjdl, t = 3.70, p < 0.01).
In the three GH-deficient children who received GH for 48 h prior to the second ACTH test, there was still a significant decrease in the maximal corticosterone response (1.7 + 0.4 to 
DISCUSSIOK
In this report we present two new findings. First, corticosterone secretion is elevated in response both to endogenous and exogenous AC'TH in children with GH deficiency. Second, a 3-day course of GH replacement therapy causes a significant decrease in corticosterone secretion (toward the normal levels) without altering cortisol secretion. Although GH receptors are present in high concentrations in the adrenal cortex (13) and there is an accumulation of labeled GH in the adrenal when ['25-1] GH is administered to rats (14) , a specific regulatory effect of GH on this tissue has not been previously recognized. Thus, these experiments demonstrate that G H has a significant effect on steroid production in the adrenal cortex.
This study was prompted by the observation that children with GI3 deficiency often have poorer recovery from insulin-induced hypoglycemia than do children without GI-1 deficiency. The poor recovery suggested a defect in a counter regulatory hormone such as a glucocorticoid. In fact, cortisol measurements during the test were frequently made to evaluate simultaneously pituitary reserves of ACTH and the response of the adrenal cortex. Because both cortisol and corticosterone are produced in relatively large amounts in humans. it seemed appropriate to measure both compounds. As shown in Table 1 , although there was no statistically significant difference in the other parameters we measured, there was almost a 2-fold greater increase in corticosterone secretion in children with GH deficiency when compared to normal children. This effect could be caused either by a difference in the secretion of the pituitary trophic hormone or by a difference in the effect of the trophic hormone on the adrenal cortex itself, To distinguish these possibilities we developed a protocol for repeated AC'TH administration. If the corticosterone secretion was normal after stimulation by exogenous ACTH, then the difference must be at the pituitary level; if the corticosterone secretion was exaggerated, then the difference must be in the adrenal cortex itself.
Previously, it has been shown that when ACTH is administered on sequential days, the amount of cortisol secreted in response to the second ACTH bolus is increased. However, when the second test is delayed for at least 3 days, there is no such increase (1 5). In order to avoid the effect of repeated injections of ACTH on adrenal secretion, we performed the ACTH stimulation tests 3 days apart. We found a substantial decrease in corticosterone following GH treatment although there was no effect on serum cortisol levels. The magnitude of the change in corticosterone levels in GH-deficient children was three times larger than the change seen in normal children on the same protocol. Thus, GI1 modulates the production of individual glucocorticoids in the adrenal cortex itself. Since the difference in structure between cortisol and corticosterone is only the prescnce of an hydroxy group at the 17 position, GH apparently modulates glucocorticoid production by regulating the amount of 17-hydroxylase activity.
Most studies of the efTect of GH on adrenal function have used the rat as a model. In intact rats GH treatment results in an increase in corticosterone synthesis probably due to an incre'ase in mitochondria1 cholesterol side-chain cleavage activity (1 6, 17). In hypophysectomized rats, combined replacement of GH and PICTH results in an increased trophic effect compared to that seen with ACTH alone. There is an increased activity of all of the microsomal hydroxylases, but it is difficult to separate the effects of G H in this system from those of ACTH itself (1%). Thus, in both of these experiments with rats, corticosterone secretion increased in response to GH administration and this is the exact opposite of our observation in humans. However, there are two significant differences between our studies in humans and the studies with rats. First, a rat model with isolated G H deficiency does not exist. Thus, the first experiment evaluated pharmacological doses of GH and the second experiment attempted to evaluate combined deficiency of all hormones secreted by the anterior pituitary. Second, rats use only corticosterone as a glucocorticoid and do not synthesize cortisol whereas in humans, cortisol is the major glucocorticoid and corticosterone is produced in much smaller amounts. In fact since the apparent target of G H action in the human adrenal is the 17-hydroxylase enzyme activity and since that enzyme activity is not used by the rat to produce glucocorticoids, G H cannot be acting in the rat adrenal cortex in the same manner and, consequently, the rat is not a good model for the process. The increase in corticosterone secretion during chronic GH deficiency, which would be a logical consequence of our experiments, may be a factor in the hyoglycemia frequently seen in GH-deficient children. Although both cortisol and corticosterone are bound to the glucocorticoid-binding protein, the protein has a greater afiinity for cortisol (19) . Thus, a greater amount of corticosterone would be unbound and available to the receptor for glucocorticoids. However, corticosterone is a weaker agonist for glucocorticoid activity than is cortisol and may act as an antagonist when present in excess (20) . In addition to a direct effect at the receptors for glucocorticoids in the liver, corticosterone might also serve as an antagonist in the adrenal medulla. The secretion of catecholamines is sharply decreased in children with GI-I deficiency (2 1 ). Rudman et a/. (22) showed that although the secretion of norepinephrine was unchanged in these children. the svnthesis of e~inevhrine was decreased 80-90%. The enzyme that converts norepinephrine to epinephrine (phenolethanolamine N-methyl transferase) requires a high concentration of a glucocorticoid for activity (23) . Since corticosterone is less effective as an agonist, it might serve as a partial antagonist in the medulla and not activate this enzyme. Thus, there might be a dual mechanism for the delay in the recovery process from episodes of hypoglycemia.
